Quintiles continues expansion of consultancy business

In a continued effort to expand the Quintiles Consulting arm of Quintiles Transnational Corp, a total of three new practice leaders and a business development head have been appointed to the business.

John Doyle, Adrian K McKemey, Matt Eberhart and Jim Featherstone have joined the leadership team of the firm – which provides, biotech, pharmaceutical and medical device firms with guidance on how to minimise risk while maximising commercial potential.

“Each new member of the team brings strong consulting practice-building skills, entrepreneurial capabilities and deep life sciences industry knowledge,” Jay Norman, president of Quintiles Consulting, said in a statement.

“Quintiles is well positioned to become the premier global provider of strategic consulting to the life sciences industry.”

According to the firm’s website, Quintiles Consulting has an extensive team of management consultants, including former European Union regulatory officials.

Consultants provide advice and guidance on product development, global regulatory development and compliance systems, market forecasting and disease modelling.